METHOD FOR CLINICAL DETECTION OF THE RISK OF PULMONARY ARTERY THROMBOEMBOLISM IN PATIENTS WITH ELECTROCARDIOSTIMULANT-CORRECTED ATRIOVENTRICULAR BLOCKADE Russian patent published in 2006 - IPC A61B10/00 

FIELD: medicine, cardiology.

SUBSTANCE: in patients it is necessary to determine the availability of the following clinical signs: the risk for alternative diagnosis and availability of hemoptysis followed by evaluation of each sign in points, correspondingly, 3 and 1 with subsequent establishing the diagnosis by their total. Moreover, additionally, it is necessary to detect the availability of other clinical signs: 2 and more respiratory and/or cardiac symptoms being typical for pulmonary artery thromboembolism to evaluated as 3 points. The appearance of atrial fibrillation signs at ECG should be evaluated as 1.5 points; The fact of electrocardiostimulant (ECS) implantation in previous 6 mo should be estimated as 1 point; the availability of venous thrombosis in the upper limbs after ECS-implantation should be estimated as 1 point. The absence of any out of the above-mentioned clinical signs should be evaluated as 0 points. Then it is necessary to calculate the sum of points obtained and at the sum being above 6 one should conclude upon, correspondingly, high, at the sum ranged 2-6 points - moderate and at the sum being below 2 - low clinical risk of pulmonary artery thromboembolism. The innovation provides increased information value of detection in such patients.

EFFECT: higher accuracy of detection.

3 ex, 1 tbl